Search Result for &#039;advanced&#039;

New immune therapies are considered a promising lead for treating recurring acute myeloid leukemia (AML). Antibodies are able to eliminate ...

Clinical trials, radiation oncology research to be featured at ASTRO’s Annual Meeting

ARLINGTON, Va., Sept. 12, 2017 - The press program for the 2017 Annual Meeting of the American Society for Radiation ...

New data on PM1183 sees a response rate of 36 percent as single agent in patients with SCLC

Madrid, September 12th, 2017.- PharmaMar (MSE:PHM) has presented today during the European Society for Medical Oncology congress (ESMO), held in ...

Best of ESMO 2017 Congress

LUGANO-MADRID, 12 September, 2017 - ESMO 2017 was a truly global event with nearly 24,000 participants from 131 countries. The ...

A new tool for tracking biological age at every level — Young.AI beta

Credit: Insilico Medicine,Inc. Tuesday, September 12th, 2017, Basel, Switzerland - Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in ...

New research to treat acute malnutrition

Credit: Kim Fleischer Michaelsen Researchers from the University of Copenhagen and humanitarian organizations have conducted a large study in Burkina ...

‘Superbug’ bacteria gang up on us, fueled by antibiotic use, nursing home study suggests

ANN ARBOR, Mich. ¬- What's worse than getting exposed to a kind of bacteria that modern antibiotics can't kill? Getting ...

Osimertinib improves progression-free survival in patients with EGFR mutated lung cancer

LUGANO-MADRID, 9 September, 2017 - Osimertinib improves progression-free survival by 54% compared to standard first line therapy in patients with ...

The 2017 Balzan Prizewinners announced today in Milan

Milan, 11 September 2017 - The names of the 2017 Balzan Prizewinners were disclosed today in a public announcement: Aleida ...

Combination targeted adjuvant therapy doubles relapse-free survival in stage III melanoma

LUGANO-MADRID, 11 September, 2017 - Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage ...

Ramucirumab plus docetaxel improves progression-free survival in urothelial cancer

LUGANO-MADRID, 10 September, 2017 - Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who ...

Mature results favor pembrolizumab as second-line treatment for bladder cancer

LUGANO-MADRID, 10 September, 2017 - Mature results from the KEYNOTE-045 trial to be presented today at the ESMO 2017 Congress ...

Proteins keep a grip on cells

Credit: Osaka University (Osaka, Japan) While you are what you eat, cells are what they touch. The cells with which ...

Scientists construct first predictive model of inflammatory bowel disease

STAMFORD, Conn. & NEW YORK, NY -- September 11, 2017 -- Scientists at the Icahn School of Medicine at Mount ...

Airline industry could fly thousands of miles on biofuel from a new promising feedstock

Credit: Claire Benjamin/University of Illinois A Boeing 747 burns one gallon of jet fuel each second. A recent analysis from ...

Key process to be modernized in production of life-saving drugs, food preservation

Credit: (Purdue University image/Erin Easterling) WEST LAFAYETTE, Ind. - A consortium of experts is working to modernize a process that ...

Body’s own defense against ALS actually drives disease progression at later stages

Credit: Tom Maniatis/Columbia University's Zuckerman Institute NEW YORK -- Columbia scientists have discovered that one of the body's natural defenses ...

Ambry Genetics & NorthShore University HealthSystem partner to advance precision medicine

Credit: Jonathan Hillenbrand Aliso Viejo, CA and Evanston, IL (September 12, 2017): Ambry Genetics (Ambry), a leading clinical genetics-testing lab, ...

Study identifies factors that limit work ability of young adult cancer survivors